• Thurs news: AbbVie Parkinson’s drug. Arch raises $3B biotech fund. Biogen dropping failed Sage tremor drug. AZ gets sought-after Tagrisso OK. Pfizer withdrawing sickle cell med. See more on our front page

Galderma is a disaster...

Galderma used to be a great derm player in the industry. Then, EQT took over and began the descent into mediocrity and failure. The real talent left, the rest were downsized, and the suck-ups remain. And don't forget the no-talent sociopaths who were hired to manage the decline. Pathetic company now. When will this misery end?
 




There comes a time when you should quit your job and move bank into your mommy house. Most of the sales slackers should be cut immediately. Overpaid, barely work a half day, and always whining. Let’s start chopping. Keep chopping

HR.